MEMBRANE DYNAMICS AND FUNCTIONAL EFFECTS ON MYELOMA CELLS AFTER DARATUMUMAB TREATMENT

被引：0
作者：
Yakymiv, Y. [1 ]
Faini, A. C. [1 ]
Castella, B. [1 ]
Morandi, F. [1 ]
Larocca, A. [1 ]
Oliva, S. [1 ]
Horenstein, A. L. [1 ]
Massaia, M. [1 ]
Malavasi, F. [1 ]
机构：
[1] Dipartimento Sci Med, Lab Immunogenet, Turin, Italy
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
CO095
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [21] Daratumumab for post-ASCT maintenance treatment of myeloma
    Kapoor, Prashant
    Kumar, Shaji
    LANCET ONCOLOGY, 2021, 22 (10) : 1345 - 1347
  • [22] Risk of infection associated with daratumumab treatment for Multiple Myeloma
    Yousif, Ammar
    Cui, Haiyan
    Russell, Samantha
    Larsen, Ashley
    Gowin, Krisstina
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S32 - S33
  • [23] Treatment of Multiple Myeloma With Daratumumab in a Kidney Transplant Patient
    Yang, Danwen
    Agrawal, Nikhil
    Marcus, Chelsea
    Roy, Neil
    Richards, Katelyn R.
    Nahas, Myrna R.
    Cardarelli, Francesca
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (04) : E488 - E491
  • [24] Actinium Labeled Daratumumab Demonstrates Enhanced Killing of Multiple Myeloma Cells over Naked Daratumumab
    Berger, Mark S.
    Thomas, Keisha
    Ekaterina, Dadachova
    Malo, Mackenzie
    Jiao, Rubin
    Allen, Kevin
    Clarke, Colin
    BLOOD, 2017, 130
  • [25] Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma
    Casneuf, Tineke
    Xu, Xu Steven
    Adams, Homer C., III
    Axel, Amy E.
    Chiu, Christopher
    Khan, Imran
    Ahmadi, Tahamtan
    Yan, Xiaoyu
    Lonial, Sagar
    Plesner, Torben
    Lokhorst, Henk M.
    van de Donk, Niels W. C. J.
    Clemens, Pamela L.
    Sasser, A. Kate
    BLOOD ADVANCES, 2017, 1 (23) : 2105 - 2114
  • [26] Daratumumab treatment reduces the stem cell mobilization potential in myeloma patients and prolongs engraftment after autologous transplant in myeloma patients
    Mehl, J.
    Bacher, U.
    Rhyner, G.
    Rufer, A.
    Soltermann, S.
    Sokler, M.
    Winkler, A.
    Daskalakis, M.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2023, 153 : 22S - 23S
  • [27] Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure
    Zamanillo, Irene
    de Alba, Lucia Medina
    Gil, Rodrigo
    de la Puerta, Rosalia
    Alonso, Rafael
    Jimenez-Ubieto, Ana
    Cedena, Maria Teresa
    Calbacho, Maria
    Ayala, Rosa
    Martinez-Lopez, Joaquin
    LIFE-BASEL, 2023, 13 (09):
  • [28] Reactivation of Resolved Hepatitis B After Daratumumab for Multiple Myeloma
    Lee, Soon Kyu
    Sung, Pil Soo
    Park, Sung-Soo
    Min, Chang-Ki
    Nam, Heechul
    Jang, Jeong Won
    Choi, Jong Young
    Yoon, Seung Kew
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (06) : E1372 - E1375
  • [29] Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma
    Shanshan Liu
    Hongwei Zhou
    Weiling Xu
    Tao Jin
    Xinyue Liang
    Xiaoxia Zhao
    Yun Dai
    Fengyan Jin
    Annals of Hematology, 2023, 102 : 967 - 969
  • [30] TREATMENT WITH DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA ASSOCIATED AL AMYLOIDOSIS
    Fazio, F.
    Basset, M.
    Milani, P.
    Foli, A.
    Nuvolone, M.
    Foa, R.
    Petrucci, M. T.
    Merlini, G.
    Palladini, G.
    HAEMATOLOGICA, 2019, 104 : 11 - 11
12345